companydata.dkProxi Biotech ApS: Financial statements 2020
CVR: 39859211
Proxi Biotech ApS (CVR 39859211) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 336,912 and a net result of DKK 84,946 compared with DKK -93,581 the year before. That is an increase of 91% compared with the year before. Equity amounted to DKK -8,535. The company had 1 employee in the financial year.
- Gross Profit
- 336,912 kr.
- Profit/Loss
- 84,946 kr.
- Equity
- -8,535 kr.
- Total Assets
- 477,407 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 337 t. | 85 t. | -9 t. | 1 |
| 2019 | - | 176 t. | -94 t. | -93 t. | 0 |
How creditworthy is Proxi Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 29, 2020, Kasper Gubba Ørtenblad has stepped down as director of Proxi Biotech ApS.
As of June 10, 2020, Rene Jørgensen is registered as adm. dir. of Proxi Biotech ApS.
As of June 10, 2020, Kasper Gubba Ørtenblad is registered as director of Proxi Biotech ApS.
As of June 9, 2020, Rene Jørgensen has stepped down as director of Proxi Biotech ApS.
As of June 9, 2020, Kasper Gubba Ørtenblad has stepped down as adm. dir. of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2019. Gross profit came to DKK 176,379, and the net result was DKK -93,581.
As of May 6, 2020, Rene Jørgensen is registered as director of Proxi Biotech ApS.
As of May 6, 2020, Aria Aminzadeh is registered as director of Proxi Biotech ApS.
As of April 15, 2020, JS Revision, Godkendt Revisionsaktieselskab has been appointed auditor of Proxi Biotech ApS.
As of April 15, 2020, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
About Proxi Biotech ApS
Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity amounted to DKK -1,712,625.